Liu D - Search Results

1

FDA-Approved Kinase Inhibitors in Preclinical and Clinical Trials for Neurological Disorders.

Lui A, Vanleuven J, Perekopskiy D, Liu D, Xu D, Alzayat O, Elgokhy T, Do T, Gann M, Martin R, Liu DZ. Lui A, et al. Among authors: liu dz, liu d. Pharmaceuticals (Basel). 2022 Dec 13;15(12):1546. doi: 10.3390/ph15121546. Pharmaceuticals (Basel). 2022. PMID: 36558997 Free PMC article. Review.

2

Multi-targeted anti-inflammatory drugs for the treatment of neurological disorders.

Lui A, Alzayat O, Do T, Perekopskiy D, Gann M, Elgokhy TS, Gao J, Liu D. Lui A, et al. Among authors: liu d. Neural Regen Res. 2023 Apr;18(4):805-806. doi: 10.4103/1673-5374.353489. Neural Regen Res. 2023. PMID: 36204844 Free PMC article. No abstract available.

3

Combined Inhibition of Fyn and c-Src Protects Hippocampal Neurons and Improves Spatial Memory via ROCK after Traumatic Brain Injury.

Ye Z, Izadi A, Gurkoff GG, Rickerl K, Sharp FR, Ander BP, Bauer SZ, Lui A, Lyeth BG, Liu D. Ye Z, et al. Among authors: liu d. J Neurotrauma. 2022 Apr;39(7-8):520-529. doi: 10.1089/neu.2021.0311. Epub 2022 Feb 22. J Neurotrauma. 2022. PMID: 35109711 Free PMC article.

4

The future of genomic profiling of neurological diseases using blood.

Sharp FR, Xu H, Lit L, Walker W, Apperson M, Gilbert DL, Glauser TA, Wong B, Hershey A, Liu DZ, Pinter J, Zhan X, Liu X, Ran R. Sharp FR, et al. Arch Neurol. 2006 Nov;63(11):1529-36. doi: 10.1001/archneur.63.11.1529. Arch Neurol. 2006. PMID: 17101821 Review.

5

Cell cycle inhibition without disruption of neurogenesis is a strategy for treatment of aberrant cell cycle diseases: an update.

Liu DZ, Ander BP. Liu DZ, et al. ScientificWorldJournal. 2012;2012:491737. doi: 10.1100/2012/491737. Epub 2012 Apr 1. ScientificWorldJournal. 2012. PMID: 22547985 Free PMC article. Review.

6

Repurposing cancer drugs to treat neurological diseases - Src inhibitors as examples.

Liu DZ. Liu DZ. Neural Regen Res. 2017 Jun;12(6):910-911. doi: 10.4103/1673-5374.208569. Neural Regen Res. 2017. PMID: 28761420 Free PMC article. No abstract available.

7

Excitatory and Mitogenic Signaling in Cell Death, Blood-brain Barrier Breakdown, and BBB Repair after Intracerebral Hemorrhage.

Liu DZ, Sharp FR. Liu DZ, et al. Transl Stroke Res. 2012 Jul;3(Suppl 1):62-9. doi: 10.1007/s12975-012-0147-z. Epub 2012 Mar 15. Transl Stroke Res. 2012. PMID: 24323862

8

MicroRNA-based therapeutics in central nervous system injuries.

Sun P, Liu DZ, Jickling GC, Sharp FR, Yin KJ. Sun P, et al. J Cereb Blood Flow Metab. 2018 Jul;38(7):1125-1148. doi: 10.1177/0271678X18773871. Epub 2018 Apr 30. J Cereb Blood Flow Metab. 2018. PMID: 29708005 Free PMC article. Review.

9

Inhibition of SRC family kinases protects hippocampal neurons and improves cognitive function after traumatic brain injury.

Liu DZ, Sharp FR, Van KC, Ander BP, Ghiasvand R, Zhan X, Stamova B, Jickling GC, Lyeth BG. Liu DZ, et al. J Neurotrauma. 2014 Jul 15;31(14):1268-76. doi: 10.1089/neu.2013.3250. Epub 2014 Apr 17. J Neurotrauma. 2014. PMID: 24428562 Free PMC article.

10

Src kinase inhibition decreases thrombin-induced injury and cell cycle re-entry in striatal neurons.

Liu DZ, Cheng XY, Ander BP, Xu H, Davis RR, Gregg JP, Sharp FR. Liu DZ, et al. Neurobiol Dis. 2008 May;30(2):201-11. doi: 10.1016/j.nbd.2008.01.006. Epub 2008 Feb 9. Neurobiol Dis. 2008. PMID: 18343677 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35,585 results

Search Page